BioCentury
ARTICLE | Finance

BioNTech bonanza

Why BioNTech added U.S. investors in week’s biggest venture raise

January 5, 2018 11:33 PM UTC

BioNTech AG is the latest billionaire-backed German biotech to diversify its shareholders by adding U.S. investors, a move that could help support an eventual IPO.

On Jan. 4, the mRNA and immuno-oncology company raised $270 million in a series A round led by new investor Redmile Group. The deal was the largest in a week that saw at least 24 companies raise a total of over $1.4 billion in venture money...

BCIQ Company Profiles

BioNTech SE